-
Sector Analysis
Dermatophytosis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in dermatophytosis Therapeutics. India is projected to have the highest number of diagnosed prevalent cases of dermatophytosis in both 2024 and 2029, contributing 32.28% and 32.98% of cases, respectively. The dermatophytosis treatment market is largely saturated with generics, with antifungal agents comprising the majority of approved innovator drugs currently available. The pipeline for dermatophytosis remains limited, with no drug in the pre-registration stage, one drug in Phase...
-
Sector Analysis
Lyme Disease (LD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in LD Therapeutics. In 2024 and 2029, Germany is anticipated to have the highest number of incident cases of Lyme disease, representing a large portion of global cases. Currently, the Lyme disease market is saturated with generic drugs, and the penicillin-binding protein (PBP) inhibitor drug class dominates the approved innovator drugs currently available to treat Lyme disease. The Lyme disease pipeline holds 23 molecules, with no asset...
-
Thematic Analysis
FDI Trends in Europe (2025)
Europe experienced a robust growth phase characterized by increased project numbers and capital expenditures from 2023 to 2024, . Europe's share in opened Greenfield Foreign Direct Investment (FDI) projects, dominated by Western Europe, rose to 40% in 2024. Despite visible FDI opportunity, Eurozone GDP growth stunted at 0.9% in 2024, with structural issues like low productivity, rapidly increasing bond yields, and energy costs weighing on industrial competitiveness Despite healthy levels of inward Greenfield FDI recorded in 2024, Europe’s FDI climate is facing the...
-
Sector Analysis
Bio/Pharmaceutical Outsourcing Report, August 2025
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
-
Sector Analysis
Middle East and Africa (MEA) Home Healthcare Market Summary, Competitive Analysis and Forecast to 2029
Home Healthcare in Middle East & Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Home healthcare refers to medical care provided in a patient's home by a healthcare agency following a doctor's orders or prescriptions. It is care provided to those unable to...
-
Sector Analysis
Middle East and Africa (MEA) Veterinary Medicine Market Summary, Competitive Analysis and Forecast to 2029
Veterinary Medicine in Middle East & Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Veterinary medicine is concerned with preventing, controlling, diagnosing, and treating diseases affecting the health of both food-producing and companion animals and preventing the transmission of animal diseases...
-
Sector Analysis
North America Veterinary Medicine Market Summary, Competitive Analysis and Forecast to 2029
Veterinary Medicine in North America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Veterinary medicine is concerned with preventing, controlling, diagnosing, and treating diseases affecting the health of both food-producing and companion animals and preventing the transmission of animal diseases to humans....
-
Sector Analysis
South America Home Healthcare Market Summary, Competitive Analysis and Forecast to 2029
Home Healthcare in South America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Home healthcare refers to medical care provided in a patient's home by a healthcare agency following a doctor's orders or prescriptions. It is care provided to those unable to receive essential...
-
Sector Analysis
South America Veterinary Medicine Market Summary, Competitive Analysis and Forecast to 2029
Veterinary Medicine in South America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Veterinary medicine is concerned with preventing, controlling, diagnosing, and treating diseases affecting the health of both food-producing and companion animals and preventing the transmission of animal diseases to humans....